Understanding how β1 integrin maintains postnatal beta-cell insulin secretion and survival could aid in the development of tissue engineering strategies for a bioartificial endocrine pancreas, a new strategy for cell-based therapeutic approaches for the treatment of both type 1 and type 2 diabetes. Here, INS is linked to type 2 diabetes mellitus.